Schizophrenia Clinics
This is a two-part study designed to assess the effects of a new drug (AQW051) for schizophrenia. In the first part, scientists will assess brain function and memory in people with schizophrenia. The second part of the study will involve determining the effects of different doses of the study medication. This national study is currently recruiting patients.
Read moreMore information on "Schizophrenia Clinics"
From Our Experts
New Treatment for Women with Schizohprenia: Estrogen?
There's some interesting new research about the possible benefits of adding estrogen to the treatment of women with schizophrenia. In a... Read more »
The Ethics of Clinical Trials
There is a lot of controversy surrounding research trials using human subjects to investigate new psychiatric medications. Maybe it's just... Read more »
The Belmont Report and Modern Clinical Trials
In my last entry, I discussed some of the many ethical problems with the design and implementation of the Tuskegee Syphilis Study and how... Read more »
Schizophrenia And Recovery: A Firsthand Account
Kurt Snyder is the lead author on the book Me, Myself and Them: a Firsthand Account of One Young Person's Experience with Schizophrenia. ... Read more »
Virginia Tech Tragedy Sharpens Focus on Relationship Between Violence...
The April 16th shooting at Virginia Tech which led to over 30 students and faculty killed was the worst of its kind in U.S. history. ... Read more »
From Our Sources
Clinical Trial: Effects of a New Schizophrenia Med
This is a study to compare the safety and cognitive effects of a new drug (GSK239512) to a placebo in people who have schizophrenia. This national... Read more »
Clinical trial: New drug for schizophrenia
This is a study to examine how well a new drug for schizophrenia--currently known as AQW051--helps enhance various kinds of brain function in people... Read more »
Clinical trial: Geodon and teen schizophrenia
This is a study to determine if flexibly-dosed Geodon is a safe and effective treatment for adolescents with schizophrenia. This international study... Read more »
Clinical trial: New drug for schizophrenia
This is a study to compare the effects of a new drug, paliperidone palmitate, with Risperdal Consta in people who suffer from schizophrenia. This... Read more »
Clinical trial: Vitamin supplements and schizophrenia
This study will evaluate the effectiveness of folate and B12 supplementation in reducing negative symptoms in people with schizophrenia. This study... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
